Global Antithrombotic Agent Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Antithrombotic Agent Market Insights, Forecast to 2034
An antithrombotic agent is a drug that reduces the formation of blood clots (thrombi). Antithrombotics can be used therapeutically for prevention (primary prevention, secondary prevention) or treatment of a dangerous blood clot (acute thrombus).
There are two main classes of antithrombotic agentsanticoagulants and antiplatelet agents.
Anticoagulants slow down the clotting process by inhibiting the formation or function of blood clotting factors. Common anticoagulants include heparin, warfarin, and direct oral anticoagulants (DOACs).
Antiplatelet agents prevent platelets from clumping together and forming clots. Common antiplatelet agents include aspirin, clopidogrel, and prasugrel.
Market Analysis and InsightsGlobal Antithrombotic Agent Market
Global Antithrombotic Agent market is expected to reach to US$ 38000 million in 2023, with a positive growth of %, compared with US$ 36500 million in 2022. Backed with the increasing demand from downstream industries, Antithrombotic Agent industry is evaluated to reach US$ 46440 million in 2033. The CAGR will be 3.4% during 2023 to 2033.
The growth of the market is attributed to the increasing prevalence of cardiovascular diseases, the rising demand for effective treatments for blood clots, and the growing awareness of the benefits of antithrombotic agents.
Here are some of the factors driving the growth of the antithrombotic agent market
Increasing prevalence of cardiovascular diseases
Rising demand for effective treatments for blood clots
Growing awareness of the benefits of antithrombotic agents
Increasing government investments in healthcare
Technological advancements in antithrombotic drug discovery and development
The antithrombotic agent market is expected to continue to grow in the coming years, driven by the factors mentioned above.
Report Covers
This report presents an overview of global Antithrombotic Agent market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Antithrombotic Agent market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Pfizer
Bayer
Johnson & Johnson
Boehringer Ingelheim Pharmaceuticals
Daiichi Sankyo
Sanofi
GlaxoSmithKline
Bristol Myers Squibb Pharma
Pliva
Sandoz
Pharmacia
Segment by Type
Anticoagulant
Antiplatelet Drug
Hospital
Drugs Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Antithrombotic Agent introduction, etc. Antithrombotic Agent Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Antithrombotic Agent
Chapter 13Methodology and Data Sources adopted by MRAResearch
There are two main classes of antithrombotic agentsanticoagulants and antiplatelet agents.
Anticoagulants slow down the clotting process by inhibiting the formation or function of blood clotting factors. Common anticoagulants include heparin, warfarin, and direct oral anticoagulants (DOACs).
Antiplatelet agents prevent platelets from clumping together and forming clots. Common antiplatelet agents include aspirin, clopidogrel, and prasugrel.
Market Analysis and InsightsGlobal Antithrombotic Agent Market
Global Antithrombotic Agent market is expected to reach to US$ 38000 million in 2023, with a positive growth of %, compared with US$ 36500 million in 2022. Backed with the increasing demand from downstream industries, Antithrombotic Agent industry is evaluated to reach US$ 46440 million in 2033. The CAGR will be 3.4% during 2023 to 2033.
The growth of the market is attributed to the increasing prevalence of cardiovascular diseases, the rising demand for effective treatments for blood clots, and the growing awareness of the benefits of antithrombotic agents.
Here are some of the factors driving the growth of the antithrombotic agent market
Increasing prevalence of cardiovascular diseases
Rising demand for effective treatments for blood clots
Growing awareness of the benefits of antithrombotic agents
Increasing government investments in healthcare
Technological advancements in antithrombotic drug discovery and development
The antithrombotic agent market is expected to continue to grow in the coming years, driven by the factors mentioned above.
Report Covers
This report presents an overview of global Antithrombotic Agent market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Antithrombotic Agent market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Pfizer
Bayer
Johnson & Johnson
Boehringer Ingelheim Pharmaceuticals
Daiichi Sankyo
Sanofi
GlaxoSmithKline
Bristol Myers Squibb Pharma
Pliva
Sandoz
Pharmacia
Segment by Type
Anticoagulant
Antiplatelet Drug
Segment by Application
Hospital
Drugs Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Antithrombotic Agent introduction, etc. Antithrombotic Agent Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Antithrombotic Agent
Chapter 13Methodology and Data Sources adopted by MRAResearch